Two standard treatments for vestibular schwannoma compared
Original title: Comparative analysis of stereotactic radiosurgery and microsurgery for vestibular schwannoma: a clinical and radiological evaluation.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
Both treatments are already used in regular care today.
The short version
Surgery shrank these tumors right away, and radiation kept them stable, with similar side effects either way.
What was studied. Doctors looked back at 87 patients treated for a vestibular schwannoma at one hospital between 2013 and 2024. Some had surgery to remove the tumor. Others had focused radiation, called stereotactic radiosurgery.
What they found. After surgery, tumor area went down by 76%. After focused radiation, tumors mostly stayed the same size or grew a little, by 5%. Hearing loss and facial weakness after treatment were about the same in both groups. Patients with larger tumors pressing on the brainstem tended to do better with surgery.
What this means, and what it doesn't
What it could mean: Both treatments are already used, and this supports using each one in different situations. Surgery may make sense for a larger tumor, because it removes a lot of it at once. Focused radiation may make sense when the goal is to keep the tumor from growing. Your own care team can tell you which fits your tumor and your health.
What it doesn't mean: This does not mean one treatment is better than the other for everyone. This was a look back at records from one hospital, not a trial that assigned people to a treatment. Looking back like this can miss things and cannot prove that one option caused a better result. It is not a cure, and it does not change what you should do without talking to your doctor.
Source: PubMed, July 18, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.